Literature DB >> 12800043

[Health care utilization in patients with Fibromyalgia Syndrome (FMS)].

A Müller1, M Hartmann, W Eich.   

Abstract

BACKGROUND: The purpose of the study was to examine the pain related health care utilization in patients with fibromyalgia syndrome.
METHODS: In a multicenter study six rheumatological hospitals associated in the rheumatological center of Heidelberg participated. All consecutive patients which fulfilled the ACR-criteria of fibromyalgia were assessed. Data about pain and related treatments were available from n=259 patients.
RESULTS: Patients suffered from chronic generalized pain on average for 5 years before being diagnosed as fibromyalgia. In most of the cases longlasting localized pain symptoms preceeded generalized pain. The spectrum of pain related treatments seems to be wide and arbitrary: 87% took questionable or excessive medication. 86% had some form of physiotherapy and 41% already experienced psychological treatment. 28% of the patients consulted dental surgeons including teeth extraction and 20% underwent multiple orthopaedic surgery. A mean of five different health care professionals were consulted regarding the pain problem. Treatment satisfaction rated by the patients was lowest with pharmacological and highest with psychological treatment and physiotherapy.
CONCLUSIONS: The health care-seeking behavior of fibromyalgia-patients seems to be characterized by a multitude of different treatment attempts. Treatment was often invasive and focused on localized symptoms rather than on the generalized pain syndrome. An early confirmation of the diagnosis and a more evidence based treatment is strongly indicated.

Entities:  

Year:  2000        PMID: 12800043     DOI: 10.1007/s004820000047

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  22 in total

1.  [High utilization of health care services by fibromyalgia patients].

Authors:  S Horndasch
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

2.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

3.  [Pharmacological treatment of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Berliner; W Brückle; S Ehlers; K Mönkemöller; B Moradi; F Petzke; N Uçeyler; R Wörz; E Winter; D O Nutzinger
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

4.  [Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Häuser; E Felde; C Flügge; R Häfner; M Settan; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

5.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

6.  The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial.

Authors:  Ibrahim M Moustafa; Aliaa A Diab
Journal:  Rheumatol Int       Date:  2015-03-18       Impact factor: 2.631

7.  Classifying Fibromyalgia Syndrome as a Mental Disorder?-An Ambulatory Assessment Study.

Authors:  Kristina Klaus; Susanne Fischer; Johanna M Doerr; Urs M Nater; Ricarda Mewes
Journal:  Int J Behav Med       Date:  2017-04

8.  [Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Eich; R Schmale-Grete; W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

9.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 10.  [Fibromyalgia].

Authors:  W Biewer; I Conrad; W Häuser
Journal:  Schmerz       Date:  2004-04       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.